Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab
Cécile Yelnik, S. Miranda, A. Mékinian, Estibaliz Lazaro, Thomas Quéméneur, François Provôt, Marie Frimat, S. Morell‐Dubois, Véronique Le Guern, É. Hachulla, N. Costedoat‐Chalumeau, M. Lambert
Abstract
136
Topics & Concepts
EculizumabCatastrophic antiphospholipid syndromeAntiphospholipid syndromeRefractory (planetary science)MedicineInternal medicineImmunologyThrombosisComplement systemAntibodyBiologyAstrobiologySystemic Lupus Erythematosus ResearchPeripheral Neuropathies and DisordersT-cell and B-cell Immunology